NIH-funded research R01 grant

PTEX protein export and host-cell remodeling in malaria parasite

Official title: PTEX mechanism in malaria parasite effector protein export and host cell subversion

Funded at Iowa State University · NIH-11384462 · Data updated 2026-11-12

A researcher at a university is studying how malaria parasites move proteins into host cells, which could reveal new ways to stop the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIowa State University
NIH-funded
Lab location1 site (Ames, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$364,908
NIH project number5R01HL170104-04
Project IDNIH-11384462 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable for this basic science project; the study focuses on parasite biology rather than recruiting patients.

Less likely to help

There are no direct patient participation components in this basic mechanistic study.

What this research studies

This project looks at how the malaria parasite uses the PTEX machinery to export proteins that alter the host’s red blood cells. The team will examine the roles of EXP2, PTEX150, and HSP101 to understand how proteins are selected and moved across membranes. Cryo-electron microscopy and other methods will help map how the export complex assembles and functions in the parasite and during liver and blood-stage infection. The findings could point to new targets for therapies that interrupt parasite survival and disease progression.

Why it matters

Potential benefit: If successful, the work could identify new targets for anti-malarial drugs that block parasite protein export and reduce disease severity.

How similar studies have gone: Previous work has linked PTEX function to parasite survival, with potential for translating findings into therapies, though full causal mechanisms remain to be clarified.

Where this research is happening

  • Iowa State University
    Ames, United States
    Active

Researchers

  • Principal investigator: Beck, Josh Ryan — Iowa State University
  • Study coordinator: Beck, Josh Ryan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.